<ѻýҕl>Bispecific Antibody Active in Relapsed/Refractory Small Cell Lung Cancerѻýҕl> A majority of patients obtained disease control with tarlatamab; responses proved durable Feb 01, 2023
<ѻýҕl>FDA Greenlights First Drug for ESR1-Mutated Breast Cancerѻýҕl> Elacestrant almost doubled PFS versus standard endocrine therapy in advanced ER+/HER2- disease Jan 30, 2023
<ѻýҕl>Immunotherapy Survival Gains 'Less Impressive' in Older Lung Cancer Patientsѻýҕl> Study finds median OS improvement of just 1 month for patients 75 and older Jan 26, 2023
<ѻýҕl>MDM2 Inhibitor Breaks Through in Trial of Liposarcoma, Other Advanced Malignanciesѻýҕl> Intermittent dosing dramatically reduced myelosuppression that has hindered drug class Jan 26, 2023
<ѻýҕl>New Class of Factor VIII Replacement Therapy Prevents Bleeds in Severe Hemophilia Aѻýҕl> Weekly dosing with efanesoctocog alfa reduced annualized bleeding rate by 77% Jan 25, 2023
<ѻýҕl>Inflammatory VEXAS Syndrome May Not Be So Uncommonѻýҕl> Is new disease being missed by physicians? Jan 24, 2023
<ѻýҕl>Neoadjuvant Chemo Reduces Disease Recurrence in Operable Colon Cancerѻýҕl> Consider it now "an option" for locally advanced disease, editorialists say Jan 24, 2023
<ѻýҕl>New Standard of Care for Refractory Metastatic Colorectal Cancerѻýҕl> Significant improvement in OS, PFS with addition of bevacizumab to trifluridine/tipiracil Jan 23, 2023
<ѻýҕl>What Caused a Man to Develop Friable Bleeding Nodules on His Arms and Hips?ѻýҕl> The cause lies in a lengthy history of cancer treatment, confirmed by histopathology analysis Jan 23, 2023
<ѻýҕl>'More Is Not Better' in Two First-Line Trials for Biliary Tract Cancerѻýҕl> No survival benefit with three-drug chemo regimen or clear PFS gain with anti-PD-L1/bevacizumab Jan 22, 2023
<ѻýҕl>New First-Line Standard for Metastatic Pancreatic Cancerѻýҕl> Liposomal irinotecan regimen boosts outcomes, although expert expressed concern about toxicity Jan 22, 2023
<ѻýҕl>Adding Targeted Drug to Chemo Boosts Survival in Gastric/GEJ Cancerѻýҕl> Longest overall survival reported to date with the addition of zolbetuximab to chemotherapy Jan 21, 2023
<ѻýҕl>We're Underutilizing Genetic Testing for Colorectal Cancerѻýҕl> Universal germline testing should be part of the standard of cancer care Jan 20, 2023
<ѻýҕl>Perioperative Chemo Matches Multimodal Tx for Locally Advanced Esophageal/GEJ Cancerѻýҕl> Nearly identical 3-year survival, questioning the need for radiotherapy before surgery Jan 20, 2023
<ѻýҕl>Circulating Tumor DNA Could Guide Use of Chemo in Colorectal Cancerѻýҕl> Identified patients likely to benefit following surgery, large prospective study showed Jan 19, 2023
<ѻýҕl>Short-Course Apalutamide to Reduce Active Surveillance Attrition in Prostate Cancerѻýҕl> Editorialists question whether any intervention violates principles of surveillance Jan 17, 2023
<ѻýҕl>Epstein-Barr Virus Tracking After Liver Transplant May Cut Rare Complicationѻýҕl> Observational study provides suggestive evidence Jan 17, 2023
<ѻýҕl>The Unfulfilled Promise of Cannabis for Cancer-Related Symptomsѻýҕl> Medical cannabis is currently too far removed from the standards of medical practice Jan 14, 2023
<ѻýҕl>For People With HIV, Early Anal Cancer Screening Tied to Better Outcomesѻýҕl> All people with HIV should be screened, not just men who have sex with men, researchers say Jan 13, 2023
<ѻýҕl>Off-the-Shelf T-Cell Therapy Effective Against Viral Infections After Allo-HCTѻýҕl> Produced an antiviral response in 95% of patients with six different types of infection Jan 13, 2023
<ѻýҕl>MRI-Guided Focused Ultrasound Eases Pain From Bone Metastasesѻýҕl> More responses with ultrasound, but quality-of-life scores lower vs EBRT in nonrandomized trial Jan 11, 2023
<ѻýҕl>Study Supports Routine Omentectomy in Absence of Metastasis During CRS-HIPECѻýҕl> High rate of occult metastases in patients with grossly normal omentum Jan 11, 2023
<ѻýҕl>Bariatric Surgery May Reduce Risk of Esophageal, Gastric Cancersѻýҕl> Cohort study provides "reassurance of the protective clinical benefits of weight loss surgery" Jan 11, 2023
<ѻýҕl>Zanubrutinib Shows Good Tolerance in BTK-Inhibitor Intolerant Malignanciesѻýҕl> Most patients had no recurrence of their original intolerance event Jan 10, 2023
<ѻýҕl>Post-HSCT Brentuximab Vedotin Plus Nivolumab Highly Effective in Hodgkin Lymphomaѻýҕl> However, toxic effects might limit the combination to the highest-risk patients Jan 10, 2023
<ѻýҕl>Conspiracy Theorists' Cancer Beliefs; HIV Meds and Ethnicityѻýҕl> Also in TTHealthWatch: sodium levels and health outcomes Jan 07, 2023 podcast
<ѻýҕl>Genomic Assay May Pinpoint Who Can Skip RT After Breast-Conserving Surgeryѻýҕl> Patients categorized as low risk with 16-gene signature showed no significant benefit with RT Jan 06, 2023
<ѻýҕl>More Evidence to Support Restrictive Opioid Prescribing After Cancer Surgeryѻýҕl> Significant decreases in prescription days, doses, refill requests, with few patient complaints Jan 06, 2023
<ѻýҕl>Optimizing Treatment for Older Patients With HR+ Low-Risk Breast Cancerѻýҕl> Five days of radiotherapy, five years of hormonal therapy, or somewhere in between? Jan 05, 2023
<ѻýҕl>More Extensive Resection of Low-Grade Glioma Linked to Longer Survivalѻýҕl> Across both subtypes, improved survival seen with at least 75% resection, study finds Jan 05, 2023
<ѻýҕl>Watch for New Psych Disorders in the Spouses of Cancer Patientsѻýҕl> Risk especially high within the first year after cancer diagnosis Jan 05, 2023
<ѻýҕl>Jazz Musician With Slowly Expanding Neck Mass Causing Dysphagiaѻýҕl> Alcoholism, liver dysfunction highly linked with rare disease of unknown etiology Jan 04, 2023
<ѻýҕl>Can Dying Well Be a Part of Living Well?ѻýҕl> Shoshana Ungerleider, MD, on her mission to transform end-of-life care Jan 03, 2023 podcast
<ѻýҕl>Crystal Ball Cloudy for PI3K Inhibitors' Future in Hematologyѻýҕl> After a year of negative news, some caution about throwing out the baby with the bath water Jan 02, 2023
<ѻýҕl>Adagrasib Shows Anti-Tumor Activity in Heavily Pretreated KRAS-Mutant CRCѻýҕl> Response rates of 19% alone, 46% with cetuximab in phase I/II trial Dec 21, 2022
<ѻýҕl>Early Win for Gene Therapy in Rare Form of SCIDѻýҕl> 10 infants were able to make their own T cells; safety good so far Dec 21, 2022
<ѻýҕl>Mixed Results With Hormonal Strategies for Premenopausal Breast Cancerѻýҕl> Exemestane reduced recurrence, metastasis versus tamoxifen, but no survival benefit Dec 20, 2022
<ѻýҕl>Long-Term Data Reinforce Targeted Combo Versus Single Agent for Advanced Melanomaѻýҕl> Encorafenib-binimetinib tops vemurafenib, but checkpoint inhibitors remain first-line choice Dec 19, 2022
<ѻýҕl>OS Benefit Eludes Second-Line Niraparib Maintenance in Ovarian Cancerѻýҕl> Significant PFS results demonstrated in NORA trial don't extend to overall survival Dec 17, 2022
<ѻýҕl>FDA Approves First Gene Therapy for Non-Muscle-Invasive Bladder Cancerѻýҕl> Half of patients achieved complete responses with adenoviral vector-based product Dec 16, 2022